1. Home
  2. TPHS vs CVKD Comparison

TPHS vs CVKD Comparison

Compare TPHS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPHS
  • CVKD
  • Stock Information
  • Founded
  • TPHS 1959
  • CVKD 2022
  • Country
  • TPHS United States
  • CVKD United States
  • Employees
  • TPHS N/A
  • CVKD N/A
  • Industry
  • TPHS Building operators
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • TPHS Real Estate
  • CVKD Health Care
  • Exchange
  • TPHS Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • TPHS 7.8M
  • CVKD 8.2M
  • IPO Year
  • TPHS N/A
  • CVKD 2023
  • Fundamental
  • Price
  • TPHS $0.12
  • CVKD $0.43
  • Analyst Decision
  • TPHS
  • CVKD Strong Buy
  • Analyst Count
  • TPHS 0
  • CVKD 2
  • Target Price
  • TPHS N/A
  • CVKD $3.50
  • AVG Volume (30 Days)
  • TPHS 7.1M
  • CVKD 71.6K
  • Earning Date
  • TPHS 03-30-2023
  • CVKD 08-12-2024
  • Dividend Yield
  • TPHS N/A
  • CVKD N/A
  • EPS Growth
  • TPHS N/A
  • CVKD N/A
  • EPS
  • TPHS N/A
  • CVKD N/A
  • Revenue
  • TPHS $21,231,000.00
  • CVKD N/A
  • Revenue This Year
  • TPHS N/A
  • CVKD N/A
  • Revenue Next Year
  • TPHS N/A
  • CVKD N/A
  • P/E Ratio
  • TPHS N/A
  • CVKD N/A
  • Revenue Growth
  • TPHS N/A
  • CVKD N/A
  • 52 Week Low
  • TPHS $0.08
  • CVKD $0.36
  • 52 Week High
  • TPHS $0.56
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • TPHS 43.04
  • CVKD 40.00
  • Support Level
  • TPHS $0.12
  • CVKD $0.43
  • Resistance Level
  • TPHS $0.13
  • CVKD $0.49
  • Average True Range (ATR)
  • TPHS 0.01
  • CVKD 0.02
  • MACD
  • TPHS 0.00
  • CVKD -0.00
  • Stochastic Oscillator
  • TPHS 30.79
  • CVKD 0.17

About TPHS Trinity Place Holdings Inc.

Trinity Place Holdings Inc is a real estate holding, investment, and asset management company. It is primarily engaged in owning, investing in, managing, developing or redeveloping real estate assets and real estate-related securities. It also controls a range of intellectual property assets focused on the consumer sector, including its online marketplace at FilenesBasement.com, its rights to the Stanley Blacker brand, and the intellectual property associated with the Running of the Brides event. The company generates revenue from Rental revenue, Other Income, and Sales of residential condominium units.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: